Skip to main content
FinSpry Logo
FinSpry
PHAT logo
PHAT
(NASDAQ)
Phathom Pharmaceuticals, Inc.
$10.61-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Phathom Pharmaceuticals (PHAT) Stock Price & Financial Analysis

Phathom Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$10.55 - $11.16
52-Week High$18.31
52-Week Low$7.61
Open$10.86
Volume899.73K
Average Volume (3M)1.07M
Market Cap891.07M
Shares Outstanding82.05M
Price to Sales (P/S)4.35
Price to Book (P/B)-2.64
EV/EBITDA-9.50
Revenue (TTM)204.89M
Net Income (TTM)-157.30M
Free Cash Flow (TTM)-97.56M
EPS (TTM)$-2.09
Profit Margin-76.77%
Operating Margin-47.15%
50-Day MA$11.43
200-Day MA$12.75
52-Week Change14.68%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Phathom Pharmaceuticals

What is the current stock price for PHAT?

As of the latest trading session, PHAT stock trades at $10.61. The 52-week range is $7.61–$18.31, with a day range of $10.55–$11.16.

What is the P/E ratio for PHAT?

The P/E ratio (Price-to-Earnings) for PHAT is shown in the Key Statistics section. This valuation metric helps compare Phathom Pharmaceuticals, Inc. to industry peers.

Does PHAT pay dividends?

Phathom Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PHAT?

Based on 7 analysts, the consensus for PHAT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PHAT?

Phathom Pharmaceuticals's market capitalization is $870.6M, classifying it as a small-cap company. Phathom Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.